Concordis Group Incorporated
CNGI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | – | $3 | $7 | $14 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | – | $3 | $8 | $14 |
| Revenue | $2 | $1 | $1 | $7 |
| % Growth | 77.8% | 42.1% | -89.7% | – |
| Gross Profit | $0 | $0 | $0 | $2 |
| % Margin | 24.1% | 37.6% | 52.8% | 32.4% |
| EBITDA | $0 | $0 | $0 | $1 |
| % Margin | 11.6% | 15% | 23% | 19.4% |
| Net Income | $0 | $0 | $0 | $1 |
| % Margin | 7.3% | 5.3% | 8.4% | 13.8% |
| EPS Diluted | 0.004 | 0.002 | 0.002 | 0.032 |
| % Growth | 144.4% | -10% | -93.8% | – |
| Operating Cash Flow | $19 | $106 | $2 | $1 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $19 | $106 | $2 | $1 |